Zhang et al. found that serum SOD levels were significantly lower in patients with cognitive impairment in the early phase and at 3 months after mild AIS than in those without cognitive impairment, accompanied by increased systemic inflammation biomarkers (ESR, CRP, and IL-6). This evidence concerns the gene IL6 and Cognitive impairment.